Got 90 Seconds? Then listen to TruScreen CEO Martin Dillon talk about the company’s recent success and potential transition onto the ASX. 

Listed on the New Zealand Stock Exchange (NZX), TruScreen Limited (NZX:TRU) is a medtech company focused on the development and sale of devices that provide real-time screening of cervical cancer.

The company has announced some key business milestones in the last few months, including a planned expansion in East Africa, a new distributor in Russia and a potential move from the NZX to the ASX.

Stockhead spoke to TruScreen CEO Martin Dillion at the Coffee Microcaps Conference in Sydney earlier this month.

Have a good idea for our next 90 Seconds With… segment? Email us at tv@stockhead.com.au.